What To Expect As Moderna’s Covid-19 Vaccine Commences Phase 2 Trials
- Wednesday, June 3, 2020, 7:14
- Market
- Add a comment
Moderna said that it commenced stage 2 trials for its new Coronavirus vaccine candidate mRNA-1273 last week. The company intends to enroll a total of 600 participants in the study, up from 45 participants in the phase 1 study. However, the trials should be quicker, as Moderna said it is looking…
About the Author
admin123 has written 23412 stories on this site.
